- KDCA National Institute of Health (NIH) and Korea Institute of Ceramic Engineering and Technology (KIET) announced joint research achievement

Osong, 05 June 2025 ━ The Korea Disease Control and Prevention Agency (KDCA) has announced the results of research showing that the application of a novel temperature-responsive particle—a new vaccine delivery system—to a vaccine for tuberculosis enhanced immune responses and demonstrated protective efficacy against Mycobacterium tuberculosis infection.

※ Paper Title: A temperature-responsive PLA-based nanosponge as a novel nanoadjuvant and efficient carrier of Ag85B for effective vaccine against Mycobacterium tuberculosis (Published in Cell Communication and Signaling, see attachment for reference)

This research is a collaborative achievement combining the temperature-responsive nanoparticle technology developed by Korea Institute of Ceramic Engineering and Technology (KIET) and the tuberculosis vaccine development technology from the National Institute of Health (NIH).